Bone Wax Market Report 2026

Bone Wax Market Overview

• Bone Wax market size has reached to $71.16 billion in 2025 • Expected to grow to $88.81 billion in 2030 at a compound annual growth rate (CAGR) of 4.5% • Growth Driver: Increase In Surgical Procedures Fueling The Growth Of The Market Due To Rising Prevalence Of Chronic Diseases And Need For Effective Bleeding Control • Market Trend: Advancements In Bone Putty For Enhanced Surgical Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bone Wax Market?

Bone wax is a hemostatic agent made primarily of beeswax, sometimes mixed with softening agents like isopropyl palmitate or petroleum jelly, used to physically block bleeding from bone marrow and cancellous (spongy) bone surfaces. The primary purpose of bone wax is to control bleeding from bone surfaces during surgery. The main products of bone wax include absorbable bone wax and non-absorbable bone wax. Absorbable bone wax is a hemostatic agent used in surgery to control bleeding from bone surfaces. It can be both natural bone wax and synthetic bone wax and is applied for orthopedic surgery, thoracic surgery, neurosurgery, dental or oral surgery, and others. It is used by various end-users such as hospitals, specialty clinics, ambulatory surgical centers, and others.

What Is The Bone Wax Market Growth Forecast?

The bone wax market size is expected to see steady growth in the next few years. It will grow to $88.81 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increasing preference for absorbable hemostatic agents, rising adoption of minimally invasive surgical techniques, growing demand for bioresorbable materials, expansion of specialty surgical centers, continuous product innovation in surgical biomaterials. Major trends in the forecast period include increasing adoption of absorbable bone wax products, rising demand for synthetic and bio-compatible formulations, growing use in minimally invasive surgeries, enhanced focus on infection-reducing hemostatic materials, expansion of bone wax applications in specialized surgeries.

Global Bone Wax Market Segmentation

1) By Product: Absorbable Bone Wax, Non-Absorbable Bone Wax 2) By Material: Natural Bone Wax, Synthetic Bone Wax 3) By Application: Orthopedic Surgery, Thoracic Surgery, Neurosurgery, Dental Or Oral Surgery, Other Applications 4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Absorbable Bone Wax: Gel-Based Absorbable Bone Wax, Paste-Based Absorbable Bone Wax, Solid Absorbable Bone Wax 2) By Non-Absorbable Bone Wax: Gel-Based Non-Absorbable Bone Wax, Paste-Based Non-Absorbable Bone Wax, Solid Non-Absorbable Bone Wax

What Is The Driver Of The Bone Wax Market?

The increasing surgical procedures are anticipated to drive the growth of the bone wax market in the coming years. Surgical procedures are medical operations involving manual or instrumental techniques performed to treat injuries, diseases, or abnormalities by altering body tissues. Surgical procedures are rising due to the increasing prevalence of chronic diseases, which often require operative intervention for effective management and improved patient outcomes. Bone wax is required for surgical procedures because it effectively controls bleeding from cut or traumatized bone surfaces, helping to maintain a clear surgical field and reduce complications related to blood loss. For instance, in 2024, according to the UK Health Security Agency, a UK-based government agency reported that, compared to the financial year 2022 to 2023, the number of operations submitted for mandatory orthopedic surveillance increased by 7.3% (from 102,027 operations), while voluntary surveillance showed an increase of 13.3% (from 23,070 operations). Therefore, the increasing surgical procedures will propel the growth of the bone wax industry.

Key Players In The Global Bone Wax Market

Major companies operating in the bone wax market are Johnson & Johnson, Medtronic Plc, Medline Industries Inc., Baxter International Inc., Aesculap Inc., B. Braun Melsungen AG, Healthium Medtech Limited, Surgical Specialties Corporation, GPC Medical Ltd., Qubix Medicare Private Limited, Dolphin Sutures, ABYRX Inc., Lotus Surgicals Private Limited, Bentley Healthcare Pvt. Ltd., Orion Sutures Private Limited, Surbhi Surgicals, Vinculum Sutures Private Limited, Ropana Medicure Private Limited, Adva Medical, Ethicon Inc., Teleflex Incorporated, Merit Medical Systems, Cardinal Health Inc., Smith & Nephew plc, Integra LifeSciences Corporation

Global Bone Wax Market Trends and Insights

Major companies operating in the bone wax market are focusing on developing advanced products, such as bone putty, to reduce the need for removal and minimize the risk of long-term complications. Bone putty is a moldable, biocompatible material used in surgeries to aid in bone healing or to control bleeding from bone surfaces. For instance, in September 2023, Abyrx Inc., a US-based manufacturer of biomaterials and therapeutic devices, announced the U.S. Food and Drug Administration (FDA) approval for MONTAGE settable bone putty. It represents the first FDA-approved settable bone putty specifically indicated for use in post-sternotomy cardiothoracic surgery. Its approval marks a significant milestone in surgical innovation for sternal procedures. What sets it apart is its ability to adhere directly to bleeding bone surfaces. After application, it hardens quickly to form a structure with bone-like properties, enhancing stability and hemostasis.

What Are Latest Mergers And Acquisitions In The Bone Wax Market?

In October 2023, Advent International, a US-based private equity firm, together with Warburg Pincus, a US-based private equity investment firm, acquired Baxter International’s BioPharma Solutions (BPS) business for $4.25 billion. With the acquisition, the business will now operate as a standalone contract development and manufacturing organization (CDMO) under the name Simtra BioPharma Solutions (Simtra). Simtra will maintain the same solutions and capabilities previously offered under the BPS name, ensuring the continued supply of essential pharmaceutical products globally. Baxter International is a US-based manufacturer of bone wax and bone hemostat.

Regional Outlook

North America was the largest region in the bone wax market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bone Wax Market?

The bone wax market consists of sales of sterile bone wax, skin staples and staplers, surgical meshes, and hemostatic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.